Matching study design to prescribing intention: The prevalent new-user design for studying abuse-deterrent formulations of opioids.
Bethany L DiPreteG Yeon OhDaniela C MogaNabarun DasguptaSvetla SlavovaEmily SladeChris DelcherBrian W PenceShabbar I RanapurwalaPublished in: Pharmacoepidemiology and drug safety (2024)
Careful consideration of the study design, comparator choice, and confounding by "indication" is crucial when examining ADF opioid use-related outcomes.